We conducted an in-depth analysis of a European cohort to investigate the potential causal association between ACE inhibition and lung cancer (trait: finn-b-C3_BRONCHUS_LUNG); however, we found no evidence of a causal relationship (OR, 0.959; 95% CI, 0.854–1.063; p = 0.429). This evidence concerns the gene ACE and lung cancer.